anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

151,141-151,200 of 319,975

filter-aware
06
The slide uses a bulleted list to highlight key competitive advantages and strategic positioning.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
07
The slide uses a three-stage process flow to illustrate the company's origin story and market positioning.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
08
Uses a two-part visual comparison: physical properties vs. therapeutic mechanism.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
09
The slide uses a process flow to explain the mechanism of action for Targeted Alpha Therapy (TAT).Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Solution1 hit
10
The slide uses a process diagram to explain the therapeutic mechanism of Ac-225 based radiopharmaceuticals.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Solution1 hit
11
Includes a biological process diagram and a line chart comparing excretion rates.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Solution1 hit
12
The slide uses a funnel diagram to illustrate the R&D process from molecule leads to efficacy studies, followed by a process flow showing the impact of the linker technology.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Solution1 hit
13
The slide illustrates a process flow from the imaging analogue to the clinical outcomes of population enrichment and organ safety assessment.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Solution1 hit
14
The slide uses a value-chain style flow to demonstrate operational maturity and competitive moat.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Solution1 hit
15
The slide uses a standard pharmaceutical pipeline visualization format.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Roadmap1 hit
16
The slide functions as a hybrid team bio and program introduction slide.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Roadmap1 hit
17
Includes a PET scan image demonstrating targeted tumor uptake vs normal tissue.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Roadmap1 hit
18
Uses a funnel diagram to illustrate the R&D process steps.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Roadmap1 hit
19
The slide compares tumor volume growth curves (left) with histological H&E staining results (right) to demonstrate efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Traction1 hit
20
The slide uses three distinct charts (two line graphs for different tumor types, one for large tumors) and a microscopy image to demonstrate therapeutic efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Traction1 hit
21
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Traction1 hit
22
Includes headshot of James O'Leary, MD.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · Traction1 hit
23
The slide uses a human body diagram to visually represent the systemic nature of the target.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
24
Includes specific DLT observation period assumptions and context regarding COVID-19 trial interruptions.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
25
The slide uses medical imaging to validate the efficacy of the therapeutic agent in diverse solid tumor environments.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
26
The slide demonstrates the stability of the drug's targeting mechanism over time, which is critical for multi-dose therapeutic regimens.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
27
The slide uses a medical/scientific aesthetic with an atom-like graphic overlay.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
28
The chart shows individual patient data points grouped by organ and cohort, with a clear 'Limit' bar for each organ.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Beat · TractionLoop · Cost Of Inaction1 hit
29
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
30
The slide uses a dual-panel approach to illustrate two distinct mechanisms of action for combination therapy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
31
The slide uses a standard preclinical study design (process flow) followed by two line charts comparing treatment efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
32
The slide uses a process diagram to explain the experimental design (re-challenge model) followed by a line chart showing tumor volume over time.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
33
The slide demonstrates the mechanism of action for the therapeutic effect, specifically highlighting T cell memory.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
34
The chart demonstrates synergistic efficacy in a tumor xenograft model.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
35
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
36
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
37
The slide uses a three-column layout to categorize R&D and business development activities.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
38
The slide uses a comparative structure (Rationale vs. Approach) to justify the development of a specific therapeutic candidate.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
39
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
40
Includes footnotes explaining the Series B tranche structure and pro forma cash calculation.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
41
The slide uses a table format to communicate project timelines.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
42
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
43
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
44
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
45
Fusion Pharmaceuticals | IPO Presentation Deck | 49 slidesFusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
46
The slide lists specific patent numbers and filing dates for various programs including IGF-1R, linker platforms, and radioimmunoconjugates.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
47
The slide uses a table to contrast physical properties and a medical imaging sequence to demonstrate clinical efficacy.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
48
Includes inclusion criteria and specific dosimetry constraints.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
49
Clinical trial safety data presentation.Fusion Pharmaceuticals | IPO Presentation Deck | 49 slides · Fusion Pharmaceuticals
Pitch deck Investment bank 1 hit
01
Slide 1
HSBC | Investor Conference Presentation Deck | 45 slidesHSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · What Is1 hit
02
HSBC | Investor Conference Presentation Deck | 45 slidesHSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · What Is1 hit
03
HSBC | Investor Conference Presentation Deck | 45 slidesHSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · What Is1 hit
04
The slide uses a navigation bar at the top to indicate the current section is 'Introduction'.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · What IsLoop · Golden Circle1 hit
05
The slide uses donut charts to show the percentage contribution of specific business units (RBWM and GPB) to the total Group figures.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · What IsLoop · Golden Circle1 hit
06
The slide uses a pyramid to show the hierarchy of customer segments from Personal Banking to Ultra High Net Worth.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · New BlissLoop · Golden Circle1 hit
07
The slide includes a navigation bar at the top and a disclaimer at the bottom.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · New BlissLoop · Golden Circle1 hit
08
The slide uses a combination of donut charts for financial concentration and a table for operational metrics.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · New BlissLoop · Golden Circle1 hit
09
The slide uses a split-axis bar chart style to show growth trends across four metrics.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · New BlissLoop · Golden Circle1 hit
10
HSBC | Investor Conference Presentation Deck | 45 slidesHSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · New BlissLoop · Golden Circle1 hit
11
The slide uses a red color highlight for Asia ex Japan to emphasize its growth leadership.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
12
The slide uses a waterfall-style bridge to isolate Wealth Management revenue from total WPB revenue.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
13
The slide uses a pyramid to show the relationship between customer wealth tiers and revenue generation.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
14
HSBC | Investor Conference Presentation Deck | 45 slidesHSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
15
HSBC | Investor Conference Presentation Deck | 45 slidesHSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · Situation & Context1 hit
16
The slide highlights the value proposition of the 'Jade' service tier and shows a stacked bar chart of customer growth segmented by Asia and Rest of World.HSBC | Investor Conference Presentation Deck | 45 slides · HSBC
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit